Join the Chantix group to help and get support from people like you.
Chantix News
The 3 Best Ways to Stop Smoking, Rated by Science
THURSDAY, Sept. 5, 2024 – Thinking about quitting smoking? There are three top ways to help you stop, a new review finds. According to the study, folks wanting to quit should turn to: Varenicline,...
Varenicline, Nicotine-Containing E-Cigarettes Help in Quitting Smoking
WEDNESDAY, June 19, 2024 – Varenicline and nicotine-containing electronic cigarettes (ECs) are both effective in helping individuals in quitting smoking conventional cigarettes, according to a study...
FDA Medwatch Alert: Pfizer Expands Voluntary Nationwide Recall to include All Lots of Chantix® (Varenicline) Tablets Due to N-Nitroso Varenicline Content
Pfizer is voluntarily recalling all lots of Chantix 0.5 mg and 1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-varenicline, at or above the FDA...
FDA Medwatch Alert: Pfizer Expands Voluntary Nationwide Recall to include Four Additional Lots of Chantix (varenicline) Tablets Due to N- Nitroso Varenicline Content
August 16, 2021 – Pfizer is voluntarily recalling an additional four lots of Chantix 0.5mg/1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine,...
FDA Medwatch Alert: Pfizer Issues a Voluntary Nationwide Recall for Twelve Lots of Chantix (Varenicline) Tablets Due to N-Nitroso Varenicline Content
July 19, 2021 – Pfizer is voluntarily recalling two lots of Chantix 0.5mg Tablets, two lots of Chantix 1 mg Tablets, and eight lots of a Chantix kit of 0.5mg/1 mg Tablets to the patient...
FDA Medwatch Alert: FDA Alerts Health Care Professionals and Patients to a Voluntary Recall of Chantix (varenicline) to the Warehouse Level
[7/02/2021] FDA is alerting patients and health care professionals to Pfizer’s voluntary recall of nine lots of the smoking cessation drug, varenicline (brand name Chantix), to the warehouse level. T...
FDA Medwatch Alert: Chantix (varenicline) and Zyban (bupropion): Drug Safety Communication - Mental Health Side Effects Revised
ISSUE: Based on an FDA review of a large clinical trial that FDA required the drug companies to conduct, FDA determined the risk of serious side effects on mood, behavior, or thinking with the...
FDA Medwatch Alert: Chantix (varenicline): Drug Safety Communication - FDA Updates Label to Include Potential Alcohol Interaction
ISSUE: FDA is warning that the prescription smoking cessation medicine Chantix (varenicline) can change the way people react to alcohol. Interactions between alcohol and Chantix have resulted in some ...
FDA Medwatch Alert: Chantix (Varenicline): Safety Communication - Updated Safety Review On The Risk of Cardiovascular Adverse Events
ISSUE: FDA is informing the public about the results of a large, combined analysis (called a meta-analysis) of clinical trials that compared patients who received the smoking cessation drug Chantix...
FDA Medwatch Alert: Chantix (varenicline)
Audience: Healthcare professionals, consumers [UPDATE 10/24/2011] FDA has reviewed the results from two FDA-sponsored epidemiological studies that evaluated the risk of neuropsychiatric adverse...
FDA Medwatch Alert: Chantix (varenicline): Label Change - Risk of Certain Cardiovascular Adverse Events
[UPDATED 07/22/2011] FDA has approved an updated drug label for Chantix (varenicline) to include information about the efficacy and safety of the drug in two patient populations who may benefit...
FDA Medwatch Alert: Chantix (varenicline): Label Change - Risk of Certain Cardiovascular Adverse Events
[Posted 06/16/2011] ISSUE: FDA notified healthcare professionals and patients that the Prescribing Information for this drug product will be strengthened to inform the public that use of...
FDA Medwatch Alert: Varenicline (marketed as Chantix)
[Posted 02/01/2008] FDA informed healthcare professionals and consumers of important revisions to the WARNINGS and PRECAUTIONS sections of the prescribing information for Chantix regarding serious...
FDA Medwatch Alert: Chantix (Varenicline)
[Posted 11/20/2007] FDA informed healthcare professionals of reports of suicidal thoughts and aggressive and erratic behavior in patient who have taken Chantix, a smoking cessation product. There are...